echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Ann Neurol-Cerebrospinal fluid bone marrow microvesicles can effectively predict the prognosis of multiple sclerosis

    Ann Neurol-Cerebrospinal fluid bone marrow microvesicles can effectively predict the prognosis of multiple sclerosis

    • Last Update: 2021-08-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Multiple sclerosis (MS) is a central nervous system itself immune demyelinating disease characterized by a wide heterogeneity


    immunity

    There are two entities in the earliest stages of the demyelinating spectrum of the central nervous system: Clinical Isolated Syndrome (CIS) and Radiological Isolated Syndrome (RIS)


    diagnosis



    At the same time, the activation of microglia is related to the disease progression of PMS


    Microvesicles (MVs) are extracellular vesicles released by different types of cells (including bone marrow cells) in biological fluids


    They included: 601 discharged patients diagnosed with neuroinflammation, neurodegenerative disease, or no neurological disease


    Compared with neurodegenerative diseases and the control group, CSF bone marrow microvesicles in patients with neuroinflammation are elevated


    CSF bone marrow microvesicles are elevated in patients with neuroinflammation


    Microvesicles can distinguish the relapse-remitting group from the control group (ROC curve, AUC=0.


    In addition, microbubbles are an independent predictor of the prognosis of the relapse-remitting group and the progression group


    This study confirmed that CSF bone marrow microvesicles are a clinically significant biomarker of neuroinflammation and microglia/macrophage activity in the body


    CSF bone marrow microvesicles are a clinically significant biomarker of neuroinflammation and microglia/macrophage activity in the body .






    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.